CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-27 | MCLAUGHLIN KEVIN F Director | Option exercise | +2,600 | 6,100 | ||
| 2022-04-27 | MCLAUGHLIN KEVIN F Director | Option exercise · Restricted Stock Unit | −2,600 | 0 | ||
| 2022-04-27 | MCLAUGHLIN KEVIN F Director | Grant or award · Stock Option (right to buy) | +6,500 | 6,500 | ||
| 2022-04-27 | MCLAUGHLIN KEVIN F Director | Grant or award · Restricted Stock Unit | +2,600 | 2,600 | ||
| 2022-04-27 | Rubino Alan L Director | Option exercise | +2,600 | 11,994 | ||
| 2022-04-27 | Rubino Alan L Director | Option exercise · Restricted Stock Unit | −2,600 | 0 | ||
| 2022-04-27 | Rubino Alan L Director | Grant or award · Restricted Stock Unit | +2,600 | 2,600 | ||
| 2022-04-27 | Rubino Alan L Director | Grant or award · Stock Option (right to buy) | +6,500 | 6,500 | ||
| 2022-04-27 | Hagen Heidi Director | Option exercise | +2,600 | 12,850 | ||
| 2022-04-27 | Hagen Heidi Director | Option exercise · Restricted Stock Unit | −2,600 | 0 | ||
| 2022-04-27 | Hagen Heidi Director | Grant or award · Restricted Stock Unit | +2,600 | 2,600 | ||
| 2022-04-27 | Hagen Heidi Director | Grant or award · Stock Option (right to buy) | +6,500 | 6,500 | ||
| 2022-03-01 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +10,000 | $10.95 | $110K | 55,914 |
| 2022-03-01 | Hopper Jonathan Mark Chief Medical Officer | Sale | −10,000 | $41.41 | $414K | 45,914 |
| 2022-03-01 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +10,000 | $18.00 | $180K | 55,914 |
| 2022-03-01 | Hopper Jonathan Mark Chief Medical Officer | Sale | −6,738 | $41.46 | $279K | 49,176 |
| 2022-03-01 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (right to buy) | −10,000 | 37,604 | ||
| 2022-03-01 | Hopper Jonathan Mark Chief Medical Officer | Option exercise · Stock Option (right to buy) | −10,000 | 38,750 | ||
| 2022-02-19 | Hopper Jonathan Mark Chief Medical Officer | Option exercise | +1,750 | 46,644 | ||
| 2022-02-19 | Hopper Jonathan Mark Chief Medical Officer | Shares withheld for taxes | −730 | $34.90 | $25K | 45,914 |
Page 42 of 75 · 1,497 trades